Company

MANA Therapeutics, Inc.

MANA Therapeutics develops cell therapies, including MANA-312 and MANA-412.

About

MANA Therapeutics develops cell therapies for various health conditions, including MANA-312 and MANA-412. Founded in 2018, the company is based in Arlington, US, and is led by CEO Mahmoud Mahmoudian. In November 2021, it raised USD 7.5 mn in venture debt from Silicon Valley Bank, bringing its total capital raised to USD 35.0 mn.

2Funding rounds

2Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in